Covestor’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Covestor's PCVX Position: Q3 2026 in Review
Covestor increased its Vaxcyte (PCVX) stake by 31% in Q3 2026, buying an estimated $13K and bringing the position to 939 shares worth $53K. The position accounts for 0.03% of the portfolio, ranked #711.
Covestor first reported a position in PCVX in Q4 2021 and has held it in 20 quarters since. The position peaked at $121K in Q3 2024. 259 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Covestor held 939 shares of Vaxcyte worth $53K as of Q3 2026.
- Covestor bought 223 Vaxcyte shares in Q3 2026, an estimated $13K.
- Vaxcyte made up 0.03% of Covestor's portfolio in Q3 2026, its #711 holding.
- Covestor first reported a position in Vaxcyte in Q4 2021 and has held it in 20 quarters since.
- Covestor's Vaxcyte position peaked at $121K in Q3 2024.
- 259 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.